secwatch.observer — SEC 8-K summary
======================================

Issuer:     CARDINAL HEALTH INC (CAH)
CIK:        0000721371
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0000721371-25-000053
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardinal Health raises FY25 EPS guidance to $8.15-$8.20; sets FY26 preliminary EPS $9.10-$9.30
--------------------------------------------------------------------------------

- Raising FY25 non-GAAP diluted EPS to $8.15-$8.20 (from $8.05-$8.15); 9% growth at midpoint.
- Preliminary FY26 non-GAAP diluted EPS $9.10-$9.30 (+13% growth); adjusted FCF $2.75B-$3.25B.
- Long-term FY26-FY28: 12-14% EPS CAGR; at least $10B total adjusted FCF; buybacks raised to $750M/year.
- Launched The Specialty Alliance (GI Alliance, Urology Alliance); expanding Biopharma Solutions; new distribution center planned.
- GMPD long-term target: $50M+ profit growth/year after FY26; FY25 GMPD profit narrowed to ~$130M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000053/0000721371-25-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/721371/000072137125000053/cah-20250612.htm
  HTML page:      https://secwatch.observer/filing/0000721371-25-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer